These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11410877)

  • 1. Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model.
    Chen B; Xu Y; Roskams T; Delaey E; Agostinis P; Vandenheede JR; de Witte P
    Int J Cancer; 2001 Jul; 93(2):275-82. PubMed ID: 11410877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
    Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
    Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.
    Chen B; Roskams T; de Witte PA
    Lasers Surg Med; 2002; 31(3):158-63. PubMed ID: 12224088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model.
    Chen B; de Witte PA
    Cancer Lett; 2000 Mar; 150(1):111-7. PubMed ID: 10755394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
    Du HY; Bay BH; Olivo M
    Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.
    Chen B; Roskams T; Xu Y; Agostinis P; de Witte PA
    Int J Cancer; 2002 Mar; 98(2):284-90. PubMed ID: 11857421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
    Chen B; Zupkó I; de Witte PA
    Int J Oncol; 2001 Apr; 18(4):737-42. PubMed ID: 11251168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of hexamethylhypericin and tetrabromohypericin to hypericin for their in vivo efficacy as PDT tools.
    Delaey E; Zupko I; Chen B; Derycke A; van Laar F; De Vos D; De Witte P
    Int J Oncol; 2003 Aug; 23(2):519-24. PubMed ID: 12851704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antivascular tumor eradication by hypericin-mediated photodynamic therapy.
    Chen B; Roskams T; de Witte PA
    Photochem Photobiol; 2002 Nov; 76(5):509-13. PubMed ID: 12462645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
    Boiy A; Roelandts R; de Witte PA
    J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma.
    Sanovic R; Verwanger T; Hartl A; Krammer B
    Photodiagnosis Photodyn Ther; 2011 Dec; 8(4):291-6. PubMed ID: 22122915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
    Chin W; Lau W; Cheng C; Olivo M
    Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
    Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy.
    Kamuhabwa AA; Cosserat-Gerardin I; Didelon J; Notter D; Guillemin F; Roskams T; D'Hallewin MA; Baert L; de Witte PA
    Int J Cancer; 2002 Jan; 97(2):253-60. PubMed ID: 11774272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photosensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin.
    Boiy A; Roelandts R; van den Oord J; de Witte PA
    Br J Dermatol; 2008 Feb; 158(2):360-9. PubMed ID: 18047507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins.
    Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
    Photochem Photobiol Sci; 2007 Dec; 6(12):1275-83. PubMed ID: 18046482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of the tumoritropic principle of hypericin.
    Van de Putte M; Roskams T; Vandenheede JR; Agostinis P; de Witte PA
    Br J Cancer; 2005 Apr; 92(8):1406-13. PubMed ID: 15812555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy of murine fibrosarcoma with topical and systemic administration of hypericin.
    Cavarga I; Brezáni P; Cekanová-Figurová M; Solár P; Fedorocko P; Miskovský P
    Phytomedicine; 2001 Sep; 8(5):325-30. PubMed ID: 11695874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin.
    Kamuhabwa AR; Huygens A; Roskams T; De Witte PA
    Int J Oncol; 2006 Mar; 28(3):775-80. PubMed ID: 16465384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
    Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.